Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
World Neurosurg ; 185: 254-260, 2024 05.
Article in English | MEDLINE | ID: mdl-38431213

ABSTRACT

BACKGROUND: There is a limited understanding of site-specific, quality of life (QOL) outcomes in anterior skull base surgery (ASBS). The objective of the present investigation was to characterize postoperative change in QOL outcomes for anterior skull base lesions following open and endoscopic surgery. METHODS: A comprehensive review of the literature was performed according to Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines using the PubMed, Scopus, Embase, and Cochrane databases for studies reporting pre- and postoperative, site-specific, QOL outcome measures in ASBS using validated questionnaires. Studies utilizing the anterior skull base quality of life (ASBQ) questionnaire or the skull base inventory were included. Investigations focusing on skull base surgery for pituitary lesions, as well as survey validation and non-English studies, were excluded. RESULTS: A total of 112 studies were screened; 4 studies, comprising a total of 195 patients and focusing exclusively on the ASBQ, were included in the systematic review. Using a fixed effect model for the meta-analysis, the mean ASBQ score was similar at six (3.45, P = 0.312; -0.19, 95% confidence interval: -0.57, 0.18) and 12 months postoperatively (3.6, P = 0.147; 0.3, 95% confidence interval: -0.11, 0.72) compared to baseline (3.53). CONCLUSIONS: Across a variety of anterior skull base pathologies, skull base-specific QOL demonstrated no improvement at 6 months and 12 months postsurgery. Few studies to date have published pre- and postoperative QOL data for patients undergoing ASBS, highlighting a current shortcoming in the available literature. Long-term follow-up in patients undergoing open and endoscopic approaches will be necessary to better understand and optimize outcomes for patients having ASBS.


Subject(s)
Quality of Life , Skull Base Neoplasms , Skull Base , Humans , Skull Base/surgery , Skull Base Neoplasms/surgery , Neurosurgical Procedures/methods , Treatment Outcome , Neuroendoscopy/methods
2.
Nurs Adm Q ; 44(3): 268-279, 2020.
Article in English | MEDLINE | ID: mdl-32511186

ABSTRACT

Heart failure (HF), a global public health problem affecting 26 million people worldwide, significantly impacts quality of life. The prevalence of depression associated with HF is 3 times higher than that of the general population. Evidence, though, supports the use of transitional care as a method to enhance functional status and improve rates of depression in patients with HF. This article discusses the findings of a quality improvement project that evaluated health outcomes in underserved patients with HF who participated in a transitional care home visitation program. The visitation program exemplifies the role of leadership in facilitating transitions across the health care continuum. The 2-year retrospective review included 79 participants with HF. Comparisons of outcomes were made over 6 months. Although not statistically significant, clinically significant differences in health outcomes were observed in participants who received a home visit >14 days compared with ≤14 days after hospital discharge. A home visitation program for underserved patients with HF offers opportunities to enhance care across the continuum. Ongoing evaluation of the existing home visitation program is indicated over time with the goal of offering leaders data to enhance patient and family-centered transitional care coordination.


Subject(s)
Heart Failure/therapy , Home Care Services/standards , Transitional Care/standards , Vulnerable Populations/statistics & numerical data , Adult , Female , Heart Failure/psychology , Home Care Services/trends , Humans , Leadership , Male , Middle Aged , Patient Health Questionnaire , Retrospective Studies , Transitional Care/trends , Vulnerable Populations/psychology
3.
Dermatol Clin ; 38(2): 185-190, 2020 Apr.
Article in English | MEDLINE | ID: mdl-32115127

ABSTRACT

Sexual and gender minority (SGM) individuals include, but are not limited to, those who identify as lesbian, gay, bisexual, transgender, and queer (LGBTQ). LGBTQ individuals are considered a marginalized and at-risk population, facing significant health care inequities when compared with heterosexual and cisgendered (ie, "gender-conforming") populations. They are more likely than heterosexual and cisgendered individuals to experience discrimination, bias, and dissatisfaction with the medical system. This article provides a broad overview of systemic inequalities confronting SGM patients.


Subject(s)
Healthcare Disparities , Prejudice , Sexual and Gender Minorities , Social Discrimination , Trust , Clinical Decision-Making , Dermatology , Early Detection of Cancer , Humans , Mass Screening , Papillomavirus Infections , Physician-Patient Relations , Sexually Transmitted Diseases
SELECTION OF CITATIONS
SEARCH DETAIL